Advertorial

Product hub: Capsugel® ZephyrTM – dry-powder inhalation capsule portfolio

Posted: 26 June 2019 | | No comments yet

Given patient convenience and compatibility with a range of formulations and doses, capsule based dry-powder inhalation (DPI) technology is becoming the preferred DPI drug delivery platform for respiratory and systemic applications.

Lonza’s Capsugel® customised capsules, in both gelatin and hypromellose, are optimised to provide superior performance and compatibility between the capsule/device and capsule/formulation.











To read this Product hub in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Lonza

Send this to a friend